Literature DB >> 18064751

Migraine prevalence, diagnosis, and disability.

Werner J Becker1, Jonathan P Gladstone, Michel Aubé.   

Abstract

The goal of the Canadian Migraine Forum was to work towards improving the lives of Canadians with migraine by reducing their migraine-related disability. This paper reviews the epidemiology and diagnosis of migraine, and the effects of migraine on health related quality of life. Many patients with migraine do not consult a physician for their headaches, and when they do they often do not receive a correct diagnosis. The discussion at the Forum concluded that better education, both for physicians and the public, on issues relating to migraine was a necessary step in improving migraine diagnosis. The degree of disability caused by migraine is often not recognized by society, and can be substantial for individuals with migraine. Once again, education of the public and of the health professionals who see these patients is key, so that the best migraine management can be instituted to minimize the impact of migraine on the individual, the family, and society at large.

Entities:  

Mesh:

Year:  2007        PMID: 18064751

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  3 in total

Review 1.  Guideline for primary care management of headache in adults.

Authors:  Werner J Becker; Ted Findlay; Carmen Moga; N Ann Scott; Christa Harstall; Paul Taenzer
Journal:  Can Fam Physician       Date:  2015-08       Impact factor: 3.275

2.  Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study.

Authors:  Jonathan Gladstone; Sameer Chhibber; Jagdeep Minhas; Calum S Neish; G Sarah Power; Zhiyi Lan; Driss Rochdi; Jessica Lanthier-Martel; Natacha Bastien
Journal:  Headache       Date:  2021-11-22       Impact factor: 5.311

Review 3.  Behavioral management of headache in children and adolescents.

Authors:  Noemi Faedda; Rita Cerutti; Paola Verdecchia; Daniele Migliorini; Marco Arruda; Vincenzo Guidetti
Journal:  J Headache Pain       Date:  2016-09-05       Impact factor: 7.277

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.